Background The liver has a critical role in the metabolism of glucose and lipids. Chronic
hepatitis B virus (HBV) or hepatitis C virus (HCV) infection leads to a spectrum of liver …

In addition to causing cirrhosis and hepatocellular carcinoma, hepatitis C virus (HCV) is
thought to cause hypolipidemia, hepatic steatosis, insulin resistance, metabolic syndrome …

AIM To summarise the literature data on hepatitis C virus (HCV)-infected patients concerning
the prevalence of glucose abnormalities and associated risk. METHODS We conducted a …

Hepatitis C virus (HCV) infection is associated with substantial clinical and economic burden
and is an important public health issue in Asia. The objective of this review was to …

Background Several chronic infections have been associated with cardiovascular diseases,
including C hlamydia pneumoniae, human immunodeficiency virus and viral hepatitis. This …

Background Although the prevalence of extrahepatic manifestations of chronic hepatitis C
virus (HCV) infection has been reported from Western countries, their prevalence in East …

Objective Chronic hepatitis C is a global health problem and has been associated with
coronary artery disease. Our aim was to examine the prevalence of coronary artery disease …

Direct‐acting antiviral agents (DAAs) have been widely used for chronic hepatitis C (CHC)
treatment recently. The characteristics of glucose abnormalities after DAAs therapy however …

Background/aims Hepatitis C virus (HCV) infection is associated with extrahepatic
manifestations such as metabolic abnormalities. The association between chronic hepatitis …

OBJECTIVE: The individual components of metabolic syndrome may be independent
predictors of mortality in patients with liver disease. We aimed to evaluate the prevalence of …